NCT05234775 — "Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product" trial site landscape

Public-registry site landscape for NCT05234775, “Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product”, a Hypercholesterolemia study sponsored by LIB Therapeutics LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05234775 (registry record)
Study title	Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product
Official title	Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product in Subjects With or Without Statin Therapy
Sponsor	LIB Therapeutics LLC
Condition(s)	Hypercholesterolemia
Phase	PHASE3
Listed sites	1
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT05234775.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05234775 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →